Participants were randomised to : insulin glargine with up to one insulin glulisine injection ( G + @ ) ; insulin glargine with stepwise addition of up to three insulin glulisine injections ( G + @ ) ; or twice-daily premixed @/@ insulin protamine-aspart/aspart ( PM-@ ) .